Note:This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
Company name: Listing:
Stock code: Representative: Inquiries:
Summary of Consolidated Financial Results for the Nine Months Ended December 31 2021
Enbio Holdings, Inc Tokyo
(Based on Japanese GAAP)
Minoru Nishimura | |
Takaharu Hasegawa | TEL:03-5297-7155 |
Scheduled date to file Quarterly Securities Report: | February 14, 2022 |
Scheduled date to commence dividend payments: | - |
Preparation of supplementary material on quarterly financial results: | Yes |
Holding of quarterly financial results briefing: | No |
Accounting Director
February 14, 2022
6092 URL:https://www.enbio-holdings.comPresident & Chief Operating Officer
(Amounts less than one million yen are rounded down)
1. Consolidated financial results for the nine months ended December 31, 2021 (from April 1 to December 31, 2021)
(1) Consolidated operating results (cumulative)
Percentages indicate year-on-year changes
Net sales | Operating profit | Ordinary profit | Profit attributable to owners of parent | |||||
Nine months ended December 31, 2021 Nine months ended December 31, 2020 | Millions of yen 7,340 5,491 | % 33.7 (4.5) | Millions of yen 1,070 551 | % 94.2 (25.2) | Millions of yen 1,056 488 | % 116.4 (18.3) | Millions of yen 580 327 | % 77.6 (42.2) |
(Note) Comprehensive income:
Nine months ended December 31, 2021 : 651 millions of yen 70.9%
Nine months ended December 31, 2020 : 380 millions of yen (32.3%)
Basic earnings per share | Diluted earnings per share | |
Nine months ended December 31, 2021 Nine months ended December 31, 2020 | Yen 87.52 49.76 | Yen 87.46 49.25 |
(2) Consolidated financial position
Total assets | Net assets | Equity ratio | Net assets per share | |
As of December 31, 2021 As of March 31, 2021 | Millions of yen 15,944 15,698 | Millions of yen 5,908 5,317 | % 36.5 33.7 | Yen 876.40 795.22 |
(Reference) Equity:
2. Cash dividendsAs of December 31, 2021: 5,825 millions of yen As of March 31, 2021 : 5,286 millions of yen
Annual dividends per share | |||||
First quarter-end | Second quarter-end | Third quarter-end | Fiscal year-end | Total | |
Year ended March 31, 2021 Year ending March 31, 2022 | Yen - - | Yen 0.00 0.00 | Yen - - | Yen 0.00 | Yen 0.00 |
Year ending March 31 2022 (Forecast) | 8.00 | 8.00 |
(Note) Revisions to the forecast of cash dividends most recently announced: Yes
3. Forecast of consolidated financial results for the year ending March 31, 2022 (from April 1 2021 to March 31, 2022)
Net sales | Operating profit | Ordinary profit | Profit attributable to owners of parent | Earnings per share | |||||
Full year | Millions of yen 9,107 | % 33.1 | Millions of yen 1,140 | % 84.6 | Millions of yen 1,073 | % 81.2 | Millions of yen 585 | % 92.4 | Yen 88.14 |
(Note) Revisions to the financial results forecast most recently announced: Yes
4. Notes
(1) Changes in significant subsidiaries during the Nine months ended December 31, 2021
(changes in specified subsidiaries resulting in the change in scope of consolidation):
(2) Application of special accounting methods for preparing quarterly consolidated financial statements:No No
(3) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements
Changes in accounting policies due to revisions to accounting standards and other regulations: | Yes |
Changes in accounting policies due to other reasons: | No |
Changes in accounting estimates; | No |
Restatement of prior period financial statements | No |
(4) Number of issued shares (common shares) | |
Total number of issue shares at the end of the period (including treasury shares) | |
Number of treasury shares at the end of the period | |
Average number of shares during the period (cumulative from the beginning of the fiscal year) |
As of December 31, 2021 | 6,671,700 shares | As of March 31, 2021 | 6,648,700 shares |
As of December 31, 2021 | 24,309 shares | As of March 31, 2021 | 1,109 shares |
As of December 31, 2021 | 6,637,381 shares | As of December 31, 2020 | 6,573,291 shares |
Quarterly consolidated financial statements Consolidated balance sheets
(Thousands of yen) | ||
As of March 31, 2021 | As of December 31, 2021 | |
Assets | ||
Current assets | ||
Cash and deposits | 2,015,310 | 2,961,927 |
Notes and accounts receivable - trade | 978,524 | - |
Notes and accounts receivable - trade, and contract assets | - | 1,343,632 |
Inventories | 3,119,353 | 1,645,130 |
Other | 533,042 | 574,635 |
Allowance for doubtful accounts | △30,538 | △17,705 |
Total current assets | 6,615,693 | 6,507,619 |
Non-current assets | ||
Property, plant and equipment | ||
Buildings and structures, net | 440,667 | 470,831 |
Machinery, equipment and vehicles, net | 3,891,678 | 3,810,855 |
Land | 2,852,880 | 2,968,857 |
Construction in progress | 143,119 | 258,148 |
Other, net | 3,877 | 9,896 |
Total property, plant and equipment | 7,332,223 | 7,518,589 |
Intangible assets | ||
Goodwill | 126,098 | 120,092 |
Other | 454,186 | 433,200 |
Total intangible assets | 580,285 | 553,293 |
Investments and other assets | 1,167,814 | 1,364,488 |
Total non-current assets | 9,080,322 | 9,436,371 |
Deferred assets | 2,564 | 256 |
Total assets | 15,698,580 | 15,944,247 |
Liabilities | ||
Current liabilities | ||
Accounts payable - trade | 542,705 | 768,257 |
Accounts payable - other, and accrued expenses | 52,487 | 74,972 |
Short-term borrowings | 955,300 | 590,000 |
Current portion of long-term borrowings | 1,050,209 | 1,090,669 |
Income taxes payable | 20,995 | 247,029 |
Provision for bonuses | - | 34,400 |
Provision for loss on construction contracts | - | 2,908 |
Other | 406,317 | 382,174 |
Total current liabilities | 3,028,014 | 3,190,410 |
Non-current liabilities | ||
Bonds payable | 71,500 | 40,000 |
Long-term borrowings | 6,959,732 | 6,496,458 |
Asset retirement obligations | 89,957 | 99,513 |
Derivatives liabilities | 182,905 | 171,570 |
Other | 49,290 | 38,162 |
Total non-current liabilities | 7,353,385 | 6,845,704 |
Total liabilities | 10,381,400 | 10,036,115 |
(Thousands of yen)
(Thousands of yen) | ||
As of March 31, 2021 | As of December 31, 2021 | |
Net assets | ||
Shareholders' equity | ||
Share capital | 1,794,509 | 1,796,809 |
Capital surplus | 1,873,093 | 1,876,049 |
Retained earnings | 1,743,576 | 2,274,704 |
Treasury shares | △96 | △15,421 |
Total shareholders' equity | 5,411,081 | 5,932,141 |
Accumulated other comprehensive income | ||
Valuation difference on available-for-sale securities | 46,728 | 19,261 |
Deferred gains or losses on hedges | △135,181 | △129,352 |
Foreign currency translation adjustment | △36,329 | 3,747 |
Total accumulated other comprehensive income | △124,781 | △106,343 |
Share acquisition rights | 304 | - |
Non-controlling interests | 30,575 | 82,334 |
Total net assets | 5,317,179 | 5,908,132 |
Total liabilities and net assets | 15,698,580 | 15,944,247 |
(Thousands of yen)
Quarterly Consolidated Statements of Income and Comprehensive Income Quarterly Consolidated Statements of Income (For the nine months)
(Thousands of yen) | ||
Nine months ended December 31, 2020 | Nine months ended December 31, 2021 | |
Net sales | 5,491,252 | 7,340,548 |
Cost of sales | 3,974,326 | 5,380,804 |
Gross profit | 1,516,925 | 1,959,743 |
Selling, general and administrative expenses | 965,528 | 889,122 |
Operating profit | 551,397 | 1,070,621 |
Non-operating income | ||
Interest and dividend income | 8,573 | 56,528 |
Foreign exchange gains | - | 28,500 |
Reversal of allowance for doubtful accounts | 769 | 12,463 |
Rental income from buildings | 3,759 | 3,718 |
Insurance claim income | 56,833 | 582 |
Other | 17,616 | 11,553 |
Total non-operating income | 87,553 | 113,346 |
Non-operating expenses | ||
Interest expenses | 93,051 | 94,034 |
Commission expenses | 29,276 | 26,056 |
Other | 28,517 | 7,661 |
Total non-operating expenses | 150,845 | 127,752 |
Ordinary profit | 488,104 | 1,056,214 |
Extraordinary income | ||
Gain on reversal of share acquisition rights | - | 304 |
Gain on sale of non-current assets | 11,899 | - |
Total extraordinary income | 11,899 | 304 |
Extraordinary losses | ||
Loss on retirement of non-current assets | 0 | 1,532 |
Impairment losses | - | 94,607 |
Total extraordinary losses | 0 | 96,140 |
Profit before income taxes | 500,004 | 960,378 |
Income taxes - current | 122,576 | 342,426 |
Income taxes - deferred | 24,857 | △12,251 |
Total income taxes | 147,434 | 330,175 |
Profit | 352,570 | 630,203 |
Profit attributable to non-controlling interests | 25,456 | 49,327 |
Profit attributable to owners of parent | 327,114 | 580,875 |
(Thousands of yen)
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Enbio Holdings Inc. published this content on 01 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 April 2022 06:32:08 UTC.